I do not understand and hope someone can help, why is the trial being called Phase 2/3. I have watched the CEO mention this in presentations but do not understand how a Phase 2 & 3 trial are conducted concurrently, is there FDA approval to do this announced somewhere I have missed?
My second question relates to comments regarding the Phase 2/3 trial taking 24 weeks. I understand that ODD approval can halve the timeframes, but watching other companies for example MSB new phase 3 trial and DXB's interim phase 3 results, these trials go for 3 years? Do we have approval for a 1 year trial for a combined Phase 2/3 trial, which can then also be halved by ODD approval?
Thanks in advance,
Wanderdog
I do not understand and hope someone can help, why is the trial...
-
- There are more pages in this discussion • 550 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $89.95M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.5¢ | $111.6K | 601.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 169572 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 613756 | 10 |
View Market Depth
| Last trade - 15.46pm 30/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |